Idenix Pharma (IDIX) Strength Tied to Weekend HCV Meeting in Washington

November 1, 2013 11:45 AM EDT Send to a Friend
Idenix Pharma (Nasdaq: IDIX) stock surged on Friday. In the view of analyst Alethia Young of Deutsche Bank, strength is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login